The Interplay between the Glucocorticoid Receptor and Nuclear Factor-κB or Activator Protein-1: Molecular Mechanisms for Gene Repression
The DOI matches its Crossref record; 791 of the 808 references it cites were found in a registry or an index.
Abstract
The inflammatory response is a highly regulated physiological process that is critically important for homeostasis. A precise physiological control of inflammation allows a timely reaction to invading pathogens or to other insults without causing overreaction liable to damage the host. The cellular signaling pathways identified as important regulators of inflammation are the signal transduction cascades mediated by the nuclear factor-kappaB and the activator protein-1, which can both be modulated by glucocorticoids. Their use in the clinic includes treatment of rheumatoid arthritis, asthma, allograft rejection, and allergic skin diseases. Although glucocorticoids have been widely used since the late 1940s, the molecular mechanisms responsible for their antiinflammatory activity are still under investigation. The various molecular pathways proposed so far are discussed in more detail.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It acts through the glucocorticoid receptor (GR), which modulates gene expression by suppressing pro-inflammatory signaling pathways involving transcription factors such as NF-κB and AP-1 [18].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [18]
In the citing paper
“GCs also decrease immune activation via protein-protein interactions between GR and NF-κB in the nucleus (Figure 1) (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“Moreover, chronic exposure to GCs (particularly synthetic GCs at supra-physiological levels) inhibits both innate and adaptive immunity.”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
In the citing paper
“For example, chronic GC exposure reduces circulating leukocyte counts and decreases the production of a large variety of proinflammatory cytokines including IL-1β and TNF-α (De Bosscher et al., 2003).”
From The Stressed CNS: When Glucocorticoids Aggravate Inflammation (2009) · cites this paper as De Bosscher et al., 2003
Citations
Cites
2 retracted
Watanabe, M., Yanagisawa, J., Kitagawa, H., Takeyama, K.-I., Ogawa, S., Arao, Y., Suzawa, M., Kobayashi, Y., Yano, T., Yoshikawa, H., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.6.1341 · Cited by 267
RetractedAdcock, I. M., Nasuhara, Y., Stevens, D. A., & Barnes, P. J. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702613 · Cited by 119
RetractedJenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756 · cited 3×
“By analogy with histone code (465, 469, 470, 517), the interplay of modifications at the cofactor (370, 371) and transcription factor levels (418, 518–521) may similarly have important functional implications (such as, e.”
BackgroundThe language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679 · cited 1×
“Besides acetylation, other posttranslational modifications such as phosphorylation and methylation also do occur in core histone tails (465, 466, 469, 470, 475).”
BackgroundNF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune Responses
Ghosh, S., May, M. J., & Kopp, E. B. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.225 · Cited by 5,182
Phosphorylation meets ubiquitination: the control of NF-κB activity
Karin, M., & Ben-Neriah, Y. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.621 · Cited by 4,766
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Mitogen-Activated Protein (MAP) Kinase Pathways: Regulation and Physiological Functions*
Pearson, G., Robinson, F., Beers Gibson, T., Xu, B.-E., Karandikar, M., Berman, K., & Cobb, M. H. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.2.0428 · Cited by 4,034 · cited 1×
“Many proinflammatory cytokines, aberrantly up-regulated in chronic inflammatory diseases, require the concerted activation of NF- B and AP-1, which are positively controlled by MAPK cascades (708, 709).”
BackgroundNF-κB regulation in the immune system
Li, Q., & Verma, I. M. (2002) · Nature Reviews Immunology · doi:10.1038/nri910 · Cited by 4,007
NF-κB: a key role in inflammatory diseases
Tak, P. P., & Firestein, G. S. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11830 · Cited by 3,918
Research works printed but not linked: 11
- Delerive, 2002, DNA-binding independent regulation of IκB-α gene transcription by PPARα., Mol Endocrinol, 16, 1029
- Benecke, 1998, Nuclear receptor coactivators as potential therapeutical targets: the HATs on the mouse trap., Gene Ther Mol Biol, 3, 1
- Herrlich, 2001, Cross-talk between glucocorticoid receptor and AP-1., Oncogene, 20, 2465, 10.1038/sj.onc.1204388 · DOI · Paper page
- Lidén, 2000, Glucocorticoid effects on NF-κB binding in the transcription of the ICAM-1 gene., Biochem Biophys Res Commun, 273, 1008, 10.1006/bbrc.2000.3079 · DOI
- Chen, 1999, Multiple glucocorticoid receptor transcripts in membrane glucocorticoid receptor-enriched S-49 mouse lymphoma cells., J Cell Biochem, 74, 418, 10.1002/(sici)1097-4644(19990901)74:3<418::aid-jcb10>3.0.co;2-6 · DOI · Paper page
- Chen, 1999, Association of the glucocorticoid receptor alternatively-spliced transcript 1A with the presence of the high molecular weight membrane glucocorticoid receptor in mouse lymphoma cells., J Cell Biochem, 74, 430, 10.1002/(sici)1097-4644(19990901)74:3<430::aid-jcb11>3.0.co;2-5 · DOI · Paper page
- Webster, 2001, Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative β isoform: a mechanism for the generation of glucocorticoid resistance., Proc Natl Acad Sci USA, 98, 6865, 10.1073/pnas.121455098 · DOI · Paper page
- De Vera, 1997, Dexamethasone suppresses iNOS gene expression by upregulating IκBα and inhibiting NF-κB, Am J Physiol, 273, G1290
- Han, 1999, Glucocorticoids prevent NF-κB activation by inhibiting the early release of platelet-activating factor in response to lipopolysaccharide., Eur J Immunol, 29, 1334, 10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0 · doi:10.1002/(sici)1521-4141(199904)29:04<1334::aid-immu1334>3.0.co;2-0
- Sengupta, 2000, Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells., EMBO J, 19, 6051, 10.1093/emboj/19.22.6051 · DOI
- Lee, 1998, Prolonged glucocorticoid exposure dephosphorylates histone H1 and inactivates the MMTV promoter., EMBO J, 17, 1454, 10.1093/emboj/17.5.1454 · DOI
Cited by
Items 301–400 of 918
Glucocorticoid Receptor Is Required for Skin Barrier Competence
Bayo, P., Sanchis, A., Bravo, A., Cascallana, J. L., Buder, K., Tuckermann, J., Schütz, G., & Pérez, P. (2008) · Endocrinology · doi:10.1210/en.2007-0814 · Cited by 58
Implications of glucocorticoid therapy in idiopathic inflammatory myopathies
Hanaoka, B. Y., Peterson, C. A., Horbinski, C., & Crofford, L. J. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.85 · Cited by 57
The glucocorticoid-Angptl4-ceramide axis induces insulin resistance through PP2A and PKCζ
Chen, T.-C., Benjamin, D. I., Kuo, T., Lee, R. A., Li, M.-L., Mar, D. J., Costello, D. E., Nomura, D. K., & Wang, J.-C. (2017) · Science Signaling · doi:10.1126/scisignal.aai7905 · Cited by 60
“genes in the liver (23, 34), although the glucocorticoid receptor antagonizes NFkB responses (35, 36).”
BackgroundGlucocorticoid action and the development of selective glucocorticoid receptor ligands
Cole, T. J. (2006) · Biotechnology annual review · doi:10.1016/s1387-2656(06)12008-6 · Cited by 68
Wu, Y., Ghosh, S., Nishi, Y., Yanase, T., Nawata, H., & Hu, Y. (2004) · Endocrinology · doi:10.1210/en.2004-0889 · Cited by 62
Glucocorticoids for Human Skin: New Aspects of the Mechanism of Action
Schäfer-Korting, M., Kleuser, B., Ahmed, M., Höltje, H.-D., & Korting, H. C. (2005) · Skin Pharmacology and Physiology · doi:10.1159/000084907 · Cited by 56
Lebsack, T. W., Fa, V., Woods, C. C., Gruener, R., Manziello, A. M., Pecaut, M. J., Gridley, D. S., Stodieck, L. S., Ferguson, V. L., & DeLuca, D. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22547 · Cited by 55
Cavet, M. E., Harrington, K. L., Ward, K. W., & Zhang, J.-Z. (2010) · PubMed Central · Cited by 73
Effects of glucocorticoids on Fas gene expression in bovine blood neutrophils
Chang, L., Madsen‐Bouterse, S. A., Toelboell, T., Weber, P. S. D., & Burton, J. L. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05822 · Cited by 63
“Upon glucocorticoid binding, GR dissociates from this complex and translocates into nuclei, where it initiates transcription by binding to glucocorticoid-response elements (GRE) in promoters of inducible target genes, and by interacting positively with transcriptional coactivators of the genes (Bamberger et al. 1996,…”
BackgroundRoth, J. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2006.02.013 · Cited by 69
Rijsdijk, M., van Wijck, A. J. M., Kalkman, C. J., & Yaksh, T. L. (2014) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000161 · Cited by 61
Liou, J., Chen, Z.-Y., Ho, L., Yang, S., Chang, D., Liang, C.-C., & Lai, J. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.04.056 · Cited by 54
“Various stimuli have now been shown to induce activity of AP-1 family members, including physiological agents, cellular stress, inflammatory cytokines and pharmacological compounds, as well as bacterial and viral infections (De Bosscher et al., 2003).”
BackgroundNovel interactions of the mineralocorticoid receptor
Fuller, P. J. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.01.027 · Cited by 60
“It is often termed transrepression or tethering (De Bosscher et al., 2003).”
BackgroundO-GlcNAc Transferase Is Involved in Glucocorticoid Receptor-mediated Transrepression
Li, M., Ruan, H., Singh, J. P., Zhao, L., Zhao, T., Azarhoush, S., Wu, J., Evans, R. M., & Yang, X. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.303792 · Cited by 57
“1H), which is consistent with previous reports, suggesting the existence of the HDAC-independent mechanism(s) of GR transrepression (26).”
ResultREV-ERBα influences the stability and nuclear localization of the glucocorticoid receptor
Okabe, T., Chavan, R., Costa, S. S., Brenna, A., Ripperger, J. A., & Albrecht, U. (2016) · Journal of Cell Science · doi:10.1242/jcs.190959 · Cited by 57
“KEY WORDS: Nuclear receptor, Circadian clock, Glucocorticoid receptor, REV-ERBα, HSP90”
BackgroundMostafa, M., Rider, C. F., Shah, S., Traves, S. L., Gordon, P. M. K., Miller‐Larsson, A., Leigh, R., & Newton, R. (2019) · BMC Medical Genomics · doi:10.1186/s12920-018-0467-2 · Cited by 56
Newton, R. C., King, E. M., Gong, W., Rider, C. F., Staples, K. J., Holden, N. S., & Bergmann, M. W. (2010) · Biochemical Journal · doi:10.1042/bj20091038 · Cited by 53
Yemelyanov, A. Y., Bhalla, P., Yang, X. J., Ugolkov, A. V., Iwadate, K., Karseladze, A. I., & Budunova, I. V. (2012) · Cell Cycle · doi:10.4161/cc.11.2.18945 · Cited by 57
Modelling clinical systemic lupus erythematosus: similarities, differences and success stories
Celhar, T., & Fairhurst, A. (2016) · Rheumatology · doi:10.1093/rheumatology/kew400 · Cited by 53
Martinović, J., & Filipović, D. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.06.002 · Cited by 58
Novoselova, E. G., Lunin, S. M., Khrenov, M. O., Parfenyuk, S. B., Novoselova, T. V., Shenkman, B. S., & Fesenko, E. E. (2014) · Immunobiology · doi:10.1016/j.imbio.2014.10.021 · Cited by 52
Furuya, F., Ishii, T., Tamura, S., Takahashi, K., Kobayashi, H., Ichijo, M., Takizawa, S., Kaneshige, M., Suzuki-Inoue, K., & Kitamura, K. (2017) · Scientific Reports · doi:10.1038/srep43960 · Cited by 53
Natoli, G. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.02.072 · Cited by 52
“GR, and to a lesser extent several other nuclear receptors, repress NF-jB-dependent transcriptional responses via mechanisms that are still unclear [59].”
BackgroundInflammatory regulation of glucocorticoid metabolism in mesenchymal stromal cells
Ahasan, M. M., Hardy, R., Jones, C., Kaur, K., Nanus, D., Juarez, M., Morgan, S. A., Hassan‐Smith, Z., Bénézech, C., Caamaño, J. H., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34414 · Cited by 49
A sub-pathway-based approach for identifying drug response principal network
Chen, X., Xu, J., Huang, B., Li, J., Wu, X., Ma, L., Jia, X., Bian, X., Tan, F., Liu, L., et al. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq714 · Cited by 50
Cascallana, J. L., Bravo, A., Donet, E., Leis, H., Lara, M. F., Paramio, J. M., Jorcano, J. L., & Pérez, P. (2005) · Endocrinology · doi:10.1210/en.2004-1246 · Cited by 55
“Although GCs have been reported to transcriptionally increase I B in certain cell types (32), we did not detect up-regulation of I B in the skin of K5-GR mice (13).”
BackgroundBladh, L.-G., Lidén, J., Dahlman-Wright, K., Reimers, M., Nilsson, S., & Okret, S. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.005801 · Cited by 49
“Activation of gene transcription by the GR typically requires an interaction of the DBDs of a GR homodimer with specific DNA sequences, so called glucocorticoid responsive elements (GREs), usually located in the promoter regions of target genes (De Bosscher et al., 2003).”
BackgroundThe permissive role of glucocorticoids in neuroinflammatory priming: mechanisms and insights
Frank, M. G., Watkins, L. R., & Maier, S. F. (2015) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000168 · Cited by 51
“Glucocorticoids are considered, with few exceptions, to be anti-inflammatory [1].”
BackgroundLatest perspectives on glucocorticoid-induced apoptosis and resistance in lymphoid malignancies
Clarisse, D., Offner, F. C., & Bosscher, K. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188430 · Cited by 53
Biochemical and endocrinological preparation for parturition
Terzidou, V. (2007) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2007.05.001 · Cited by 64
Moyes, K. M., Drackley, J. K., Morin, D. E., Rodriguez‐Zas, S. L., Everts, R. E., Lewin, H. A., & Loor, J. J. (2010) · Physiological Genomics · doi:10.1152/physiolgenomics.00197.2009 · Cited by 62
Reduced Glioma Growth Following Dexamethasone or Anti‐Angiopoietin 2 Treatment
Villeneuve, J., Galarneau, H., Beaudet, M., Tremblay, P., Chernomoretz, A., & Vallières, L. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2008.00139.x · Cited by 54
“Considering that glucocorticoids can suppress cytokine signaling and induce T cell apoptosis (1, 7), the question arises as to whether dexamethasone may facilitate brain tumor growth by interfering with antitumor immune responses.”
BackgroundJiang, Y., Li, Z., Liu, Y., Liu, X., Chang, Q., Liao, Y., & Pan, R. (2014) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2014.10.062 · Cited by 49
Adachi, T., Teramachi, M., Yasuda, H., Kamiya, T., & Hara, H. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.01.014 · Cited by 50
Direct interaction between estrogen receptor α and NF-κB in the nucleus of living cells
Quaedackers, M. E., van den Brink, C. E., van der Saag, P. T., & Tertoolen, L. G. J. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.05.002 · Cited by 56
“…1995;Quaedackers et al., 2001), it must be the result of a direct mechanism such as inhibition of NF-κB DNA binding or interference with components of the NF-κB transcriptional complex (Nissen and Yamamoto, 2000;De Bosscher et al., 2003;Kalaitzidis and Gilmore, 2005;Luecke and Yamamoto, 2005).”
BackgroundCiliberti, M. G., Albenzio, M., Inghese, C., Santillo, A., Marino, R., Sevi, A., & Caroprese, M. (2016) · Journal of Dairy Science · doi:10.3168/jds.2016-11688 · Cited by 51
Resetting the Stress System with a Mifepristone Challenge
Dalm, S., Karssen, A. M., Meijer, O. C., Belanoff, J. K., & de Kloet, E. R. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-018-0614-5 · Cited by 49
Hormonal Regulation of Adipogenesis
Lee, M. (2017) · Comprehensive physiology · doi:10.1002/cphy.c160047 · Cited by 50
Variation in glucocorticoid sensitivity and the relation with obesity
Lengton, R., Iyer, A. M., van der Valk, E. S., Hoogeveen, E. K., Meijer, O. C., van der Voorn, B., & van Rossum, E. F. C. (2021) · Obesity Reviews · doi:10.1111/obr.13401 · Cited by 50
Medroxyprogesterone acetate downregulates cytokine gene expression in mouse fibroblast cells
Koubovec, D., Berghe, W. V., Vermeulen, L., Haegeman, G., & Hapgood, J. P. (2004) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2004.03.006 · Cited by 47
Self-citationGlucocorticoid receptors, epidermal homeostasis and hair follicle differentiation
Pérez, P. (2011) · Dermato-Endocrinology · doi:10.4161/derm.15332 · Cited by 47
“This is in agreement with the known antagonism between GR and the IKK/NFκB pathway in many cell types including keratinocytes.(11,21) The developing skin of K5-GR mice showed a reduced proliferation rate of the keratinocytes (approximately 30%) from E16.”
ResultStress circuitry: mechanisms behind nervous and immune system communication that influence behavior
Tong, R. L., Kahn, U. N., Grafe, L. A., Hitti, F. L., Fried, N. T., & Corbett, B. F. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1240783 · Cited by 53
“NFkB can suppress GR function via direct binding that prevents GR binding to DNA, by outcompeting GRs for co-activators, and by recruiting co-repressors to GR-binding sites (69, 70).”
BackgroundCheng, Q., Morand, E. F., & Yang, Y. H. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00169 · Cited by 51
“REVIEW ARTICLE published: 17 July 2014 doi: 10.3389/fphar.2014.00169 Development of novel treatment strategies for inflammatory diseases—similarities and divergence between glucocorticoids and GILZ”
BackgroundInfluentialInflammatory targets of therapy in sickle cell disease
Owusu-Ansah, A. T., Ihunnah, C. A., Walker, A. L., & Ofori-Acquah, S. F. (2015) · Translational research · doi:10.1016/j.trsl.2015.07.001 · Cited by 52
Siegel, A. L., Bledsoe, C., Lavin, J., Gatti, F., Berge, J., Millman, G., Turin, E., Winders, W. T., Rutter, J., Palmeiri, B., et al. (2008) · Neuromuscular Disorders · doi:10.1016/j.nmd.2008.10.006 · Cited by 46
Of old and new diseases: genetics of pituitary ACTH excess (Cushing) and deficiency
Drouin, J., Bilodeau, S., & Vallette-Kasic, S. (2007) · Clinical Genetics · doi:10.1111/j.1399-0004.2007.00877.x · Cited by 46
“This mechanism is known as trans-repression and is similar to themechanismdescribed forGR repression of AP1 or NFkB-dependent transcription (37, 38).”
BackgroundExperience and the ever‐changing brain: What the transcriptome can reveal
Rubin, T. G., Gray, J. D., & McEwen, B. S. (2014) · BioEssays · doi:10.1002/bies.201400095 · Cited by 47
Medical Therapy for Inflammatory Bowel Disease
Grevenitis, P., Thomas, A. M., & Lodhia, N. (2015) · Surgical Clinics of North America · doi:10.1016/j.suc.2015.08.004 · Cited by 45
The hypothalamic–pituitary–adrenal axis in critical illness
Venkataraman, S. T., Munoz, R. A., Cândido, C., & Witchel, S. F. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9058-9 · Cited by 51
“Other glucocorticoid-responsive genes are regulated by a second mechanism involving cortisol-GR interactions with other transcription factors such as nuclear factor-κβ (NF-κβ) [14, 15 ].”
BackgroundChelli, S. M., Alagumuthu, M., Sridhar, P., Sivakumar, A., Belliraj, S. K., & Reddy, S. R. (2017) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2017.10.075 · Cited by 45
Kim, Y., Oh, T. W., Park, E., Yim, N., Park, K. J., Cho, W., & Ma, J. (2018) · Nutrients · doi:10.3390/nu10030282 · Cited by 45
GILZ as a Regulator of Cell Fate and Inflammation
Bruscoli, S., Riccardi, C., & Ronchetti, S. (2021) · Cells · doi:10.3390/cells11010122 · Cited by 49
Quidé, Y., Bortolasci, C. C., Spolding, B., Kidnapillai, S., Watkeys, O. J., Cohen-Woods, S., Carr, V. J., Berk, M., Walder, K., & Green, M. J. (2021) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.110013 · Cited by 44
Control of Inflammatory Responses: a New Paradigm for the Treatment of Chronic Neuronal Diseases
Woo, J. H., Lee, J. H., Kim, H., Park, S. J., Joe, E.-H., & Jou, I. (2015) · Experimental Neurobiology · doi:10.5607/en.2015.24.2.95 · Cited by 44
“GR is a prototype ligand-activated transcription factor that belongs to the nuclear receptor (NR) family and regulates gene expression by either transcriptional activation [21] or transcriptional repression (transrepression) [22].”
BackgroundThe long winding road to the safer glucocorticoid receptor (GR) targeting therapies
Lesovaya, E. A., Chudakova, D. A., Baida, G. E., Михайловна, Ж. Е., Игоревич, К. К., Геннадиевна, Я. М., & Budunova, I. V. (2022) · Oncotarget · doi:10.18632/oncotarget.28191 · Cited by 45
“It has been well accepted in the field that TR is an important mechanism underlying therapeutic antiinflammatory and anti-lymphoma effects of Gcs [10].”
BackgroundLavagno, L., Gunella, G., Bardelli, C., Spina, S., Fresu, L. G., Viano, I., & Brunelleschi, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.07.101 · Cited by 50
Kuryłowicz, A., Hiromatsu, Y., Jurecka‐Lubieniecka, B., Kula, D., Kowalska, M., Ichimura, M., Koga, H., Kaku, H., Bar‐Andziak, E., Nauman, J., et al. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364418 · Cited by 46
The zebrafish as an in vivo model system for glucocorticoid resistance
Schoonheim, P. J., Chatzopoulou, A., & Schaaf, M. J. M. (2010) · Steroids · doi:10.1016/j.steroids.2010.05.010 · Cited by 50
Tiwari, S., Dong, H., Kim, E. J., Weintraub, L. R., Epstein, P. M., & Lerner, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.10.009 · Cited by 47
Metabolic correlations of glucocorticoids and polyamines in inflammation and apoptosis
Bjelaković, G., Stojanović, I. R., Jevtović−Stoimenov, T., Pavlovic, D. D., Kocic, G. M., Rossi, S., Tabolacci, C., Nikolić, J., Sokolovic, D. T., & Bjelaković, L. (2010) · Amino Acids · doi:10.1007/s00726-010-0489-3 · Cited by 45
“1), such as NF-jB and AP-1, representing obvious targets for immunosuppressive therapies (De Bosscher et al. 2003; Cosı́o et al. 2005).”
InfluentialSteroid receptor coregulator diversity: What can it mean for the stressed brain?
Meijer, O. C., van der Laan, S., Lachize, S., Steenbergen, P. J., & de Kloet, E. R. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.07.004 · Cited by 49
Zhang, J., Ge, P., Liu, J., Luo, Y., Guo, H., Zhang, G., Xu, C., & Chen, H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512138 · Cited by 47
Understanding stress-effects in the brain via transcriptional signal transduction pathways
Zalachoras, I., Houtman, R., & Meijer, O. C. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.03.038 · Cited by 44
Chen, X., Tang, S., Lee, E., Qiu, Y., Wang, R., Duan, H., Dan, S., Jin, M., & Kong, D. (2015) · Life Sciences · doi:10.1016/j.lfs.2015.01.008 · Cited by 43
Ayroldi, E., Cannarile, L., Delfino, D. V., & Riccardi, C. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0558-1 · Cited by 48
Carlson, C. G., Samadi, A. K., & Siegel, A. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.003 · Cited by 46
Hop bitter acids efficiently block inflammation independent of GRα, PPARα, or PPARγ
Cleemput, M. V., Heyerick, A., Libert, C., Swerts, K., Philippé, J., Keukeleire, D. D., Haegeman, G., & Bosscher, K. D. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800493 · Cited by 48
“, GRa/NF-jB, PPAR/NF-jB, GRa/AP-1, PPAR/ AP-1,GRa/CREB), competition for coactivators, disruption of the coactivator complex, inhibition of corepressor clearance and modification of histones [54, 55].”
BackgroundSelf-citationNuclear Receptors, Inflammation, and Neurodegenerative Diseases
Saijo, K., Crotti, A., & Glass, C. K. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)06002-5 · Cited by 43
Treatment of Experimental Asthma by Decoy-mediated Local Inhibition of Activator Protein-1
Desmet, C. J., Gosset, P., Henry, E., Garzé, V., Faísca, P., Vos, N., Jaspar, F., Melotte, D., Lambrecht, B. N., Desmecht, D. J.-M., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200410-1431oc · Cited by 43
“Second, GCs and two oxidoreductase inhibitors— namely, MOL 294 and PNRI-299—are believed to exert their antiinflammatory effects in pulmonary allergy at least partly through AP-1 inhibition (8, 11 , 30, 31).”
BackgroundFriendship network position and salivary cortisol levels
Kornienko, O., Clemans, K. H., Out, D., & Granger, D. A. (2013) · Social Neuroscience · doi:10.1080/17470919.2013.795500 · Cited by 43
He, Y., & Simons, S. S. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01360-06 · Cited by 43
“While gene induction by GRs has been more extensively studied and has, in combination with induction by other steroid/nuclear receptors, provided most of the data for constructing the current model of GR action (54, 55), gene repression by GRs is of particular clinical importance due to the widespread use of glucocort…”
BackgroundLiu, W., Jiang, H.-L., Cai, L., Yan, M., Dong, S., & Mao, B. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/5292346 · Cited by 50
“…significantly counteracted LPSstimulated release of TNF-𝛼, IL-1𝛽, IL-6, and IL-8, attenuated cells influx in BALF, mitigated mucus hypersecretion, suppressed phosphorylation of NF-𝜅B p65, I𝜅B-𝛼, ΙKK𝛼/𝛽, ERK1/2, JNK, and p38MAPK, and inhibited p38MAPK andNF-𝜅B p65 expression in rat lungs.”
BackgroundBladh, L.-G., Lidén, J., Pazirandeh, A., Rafter, I., Dahlman‐Wright, K., Nilsson, S. V., & Okret, S. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0294 · Cited by 44
“In some cases, repression of gene expression seems to involve a direct GR interaction with so-called negative GREs present in target genes (8, 9).”
BackgroundInfluentialGenes Involved in the Balance between Neuronal Survival and Death during Inflammation
Glezer, I., Chernomoretz, A., David, S., Plante, M.-M., & Rivest, S. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000310 · Cited by 46
“Glucocorticoids (GCs) are potent endogenous anti-inflammatory molecules. Activated GC receptors (GRs) are able to interfere with the transactivation potential of the p65 NF-κB subunit as well as AP-1. Other mechanisms explaining the effects of GCs on gene transcription have been proposed, including the competition bet…”
BackgroundThe mechanisms of tumor suppressor effect of glucocorticoid receptor in skin
Chebotaev, D. V., Yemelyanov, A. Y., & Budunova, I. V. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20349 · Cited by 44
“Along with the control of carbohydrate, lipid, and protein metabolism, one of the major functions of glucocorticoids is the regulation of inflammatory and immune responses [1,2].”
BackgroundInfluentialGlucocorticoid circadian rhythms in immune function
Olejniczak, I., Oster, H., & Ray, D. W. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00889-2 · Cited by 45
Wang, M., Ramírez, J. A., Han, J., Jia, Y., Domenico, J. M., Seibold, M. A., Hagman, J. R., & Gelfand, E. W. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.027 · Cited by 42
El-Feky, E. M., & Aziz, A. A. A. E. (2014) · Egyptian Journal of Anaesthesia · doi:10.1016/j.egja.2014.11.005 · Cited by 41
Cellular stress response mechanisms as therapeutic targets of ginsenosides
Qi, H., Li, L., & Ma, H. (2017) · Medicinal Research Reviews · doi:10.1002/med.21450 · Cited by 42
The glucocorticoid receptor DNA-binding domain recognizes RNA hairpin structures with high affinity
Parsonnet, N. V., Lammer, N. C., Holmes, Z. E., Batey, R., & Wuttke, D. S. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz486 · Cited by 41
Impact of cholesterol-pathways on breast cancer development, a metabolic landscape
González-Ortiz, A., Galindo‐Hernández, O., Acevedo, G. N. H., Hurtado-Ureta, G., & García‐González, V. (2021) · Journal of Cancer · doi:10.7150/jca.54637 · Cited by 43
“Specifically, in breast cancer cell lines, GR exerts anti-apoptotic actions through the activation of NF-κB signaling [138-140].”
BackgroundKatari, O., & Jain, S. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.2011857 · Cited by 41
“into account the activation of glucocorticoid receptor by cortisol, which may further experience transrepression with nuclear factor-κB interaction [46,47].”
BackgroundNuclear receptors in the cross-talk of drug metabolism and inflammation
Gerbal‐Chaloin, S., Iankova, I., Maurel, P., & Daujat‐Chavanieu, M. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.756011 · Cited by 46
“In the same way, cross-talk between GR and many other transcription factors has been extensively described (De Bosscher et al., 2003; Kassel and Herrlich, 2007; Van Bogaert et al., 2010).”
BackgroundWigenstam, E., Koch, B. L., Bucht, A., & Jonasson, S. (2014) · Toxicology · doi:10.1016/j.tox.2014.12.008 · Cited by 41
Giembycz, M. A., & Newton, R. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17969-3_18 · Cited by 43
Antiinflammatory Effects of Budesonide in Human Fetal Lung
Barrette, A. M., Roberts, J. K., Chapin, C. J., Egan, E. A., Segal, M. R., Osés-Prieto, J. A., Chand, S., Burlingame, A. L., & Ballard, P. L. (2016) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2016-0068oc · Cited by 44
“The difference in potency for induction versus repression effects may reflect, at least in part, a higher affinity of GR for NF-kB and c-jun/c-fos (activator protein 1) transcription factors than for the GRE in promoters of induced genes (46, 47).”
BackgroundHofkens, W., Storm, G., van den Berg, W. B., & van Lent, P. L. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.02.060 · Cited by 40
Freeman, A. I., Munn, H. L., Lyons, V., Dammermann, A., Seckl, J. R., & Chapman, K. E. (2004) · Journal of Endocrinology · doi:10.1677/joe.1.05773 · Cited by 40
“GR negatively regulates transcription through several different mechanisms, including DNA-independent (for example, by interfering with AP-1- or NF-kB- mediated transcriptional activation; reviewed by de Bosscher et al. (2003)) and DNAdependent means (for example, by binding to negative glucocorticoid response element…”
BackgroundInfluentialOrphan nuclear receptor NR2F6 acts as an essential gatekeeper of Th17 CD4+ T cell effector functions
Hermann‐Kleiter, N., & Baier, G. (2014) · Cell Communication and Signaling · doi:10.1186/1478-811x-12-38 · Cited by 40
“Consistent with this observation, it is well documented that several other NRs, such as the steroid receptors, PPAR, RXR, RAR, and VDR repress the ability of NFAT and/or AP-1 to transcribe their target genes in T cells and this interference is the established basis for the anti-inflammatory actions of corticosteroids…”
BackgroundThe Role of Steroid Hormones in the Modulation of Neuroinflammation by Dietary Interventions
Vasconcelos, A. R., Cabral‐Costa, J. V., Mazucanti, C. H., Scavone, C., & Kawamoto, E. M. (2016) · Frontiers in Endocrinology · doi:10.3389/fendo.2016.00009 · Cited by 44
Tsugita, M., Iwasaki, Y., Nishiyama, M., Taguchi, T., Shinahara, M., Taniguchi, Y., Kambayashi, M., Nishiyama, A., Gómez-Sánchez, C. E., Terada, Y., et al. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.12.008 · Cited by 42
Tse, A. K., Wan, E. C. K., Shen, X., Zhu, G., Cheung, H., Yang, M., & Fong, W. F. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.02.022 · Cited by 39
McLean, K. M., Duffy, J. Y., Pandalai, P. K., Lyons, J. M., Bulcao, C. F., Wagner, C. J., Akhter, S. A., & Pearl, J. M. (2007) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.10.011 · Cited by 39
Fu, Y., Zhao, H., Zhang, T., & Chi, F. (2010) · Auris Nasus Larynx · doi:10.1016/j.anl.2010.07.008 · Cited by 39
Reduced Glucocorticoid Receptor Expression Predicts Bladder Tumor Recurrence and Progression
Ishiguro, H., Kawahara, T., Zheng, Y., Netto, G. J., & Miyamoto, H. (2014) · American Journal of Clinical Pathology · doi:10.1309/ajcpu8ucezyg4wtv · Cited by 38
Wilson, S. M., Shen, P., Rider, C. F., Traves, S. L., Proud, D., Newton, R. C., & Giembycz, M. A. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0902738 · Cited by 38
“The classical repressive mode of glucocorticoid action is termed transrepression, in which the activity of key proinflammatory transcription factors, such as NF- B and AP-1, is inhibited via direct interactions with the ligand-bound glucocorticoid receptor (GR) (19).”
BackgroundErg and AP-1 as determinants of glucocorticoid response in acute lymphoblastic leukemia
Chen, D. W.-C., Saha, V., Liu, J.-Z., Schwartz, J., & Krstic–Demonacos, M. (2012) · Oncogene · doi:10.1038/onc.2012.321 · Cited by 45
Rani, C. S. S., Elango, N., Wang, S.-S., Kobayashi, K., & Strong, R. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051219 · Cited by 38
“Glucocorticoids use several mechanisms to bring about transactivation or transrepression of genes (De Bosscher et al., 2003; Rhen and Cidlowski, 2005; Newton and Holden, 2007).”
BackgroundArango-Lievano, M., & Jeanneteau, F. D. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.08.005 · Cited by 41
Hormonal therapy in traumatic spinal cord injury.
Ludwig, P. E., Patil, A. A., Chamczuk, A. J., & Agrawal, D. K. (2017) · Europe PMC (PubMed Central) · Cited by 44
Metadata
- Authors
- De Bosscher, K., Vanden Berghe, W., & Haegeman, G.
- Affiliations
- Department of Molecular Biology, Ghent University, K. L. Ledeganckstraat 35, 9000 Gent, Belgium
- Ghent University (BE)
- Corresponding author
- Haegeman, Guy
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2003-08-01
- Volume
- 24
- Issue
- 4
- Pages
- 488-522
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2053125671
- Cited by
- 898
- References
- 808
- Citations by year
- 2026: 22 · 2025: 25 · 2024: 13 · 2023: 24 · 2022: 22 · 2021: 41 · 2020: 30 · 2019: 20 · 2018: 26 · 2017: 46 · 2016: 42 · 2015: 52 · 2014: 47 · 2013: 41 · 2012: 48
- FWCI
- 3.93
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- glucocorticoid receptor, NF-κB, activator protein-1, gene repression, anti-inflammatory mechanism, inflammation, signal transduction, glucocorticoids, transcriptional regulation, rheumatoid arthritis, asthma, allograft rejection, allergic skin diseases
- MeSH terms
- Gene Expression Regulation, Glucocorticoids, Humans, Inflammation, Receptors, Glucocorticoid, Signal Transduction, NF-kappa B, Transcription Factor AP-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.